Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.18 USD | +0.44% |
|
+4.37% | +6.96% |
| 30/06 | Edwards Lifesciences Secures US FDA Approval for Ecliptis System | MT |
| 29/06 | Edwards Lifesciences Corporation(NYSE:EW) added to Russell Midcap Value Benchmark | CI |
| Market Cap | 5.23TCr 4.58TCr 4.22TCr 3.94TCr 7.43TCr 4,94100Cr 7.59TCr 51TCr 20TCr 2,43700Cr 20TCr 19TCr 8,46400Cr | P/E 2026 * |
32.4x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.88TCr 4.27TCr 3.94TCr 3.68TCr 6.93TCr 4,61200Cr 7.08TCr 47TCr 18TCr 2,27500Cr 18TCr 18TCr 7,90100Cr | EV / Sales 2026 * |
7.23x | EV / Sales 2027 * | 6.37x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.44% | ||
| 1 week | +4.37% | ||
| Current month | +5.45% | ||
| 1 month | +6.07% | ||
| 3 months | +14.92% | ||
| 6 months | +4.99% | ||
| Current year | +6.96% |
| 1 week | 85.46 |  | 92.88 |
| 1 month | 83.17 | | 92.88 |
| Current year | 74.66 | | 92.88 |
| 1 year | 72.3 | | 92.88 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/06 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 29/05 | Sell | Controller/Auditor | -568 | 0.0001% | ||
| 27/05 | Sell | Executive/Senior Manager | -23,145 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.44% | +4.37% | +16.58% | +0.82% | 5.23TCr | |
| -1.29% | +9.00% | +24.04% | -0.73% | 19TCr | |
| +0.31% | -0.20% | -23.93% | +21.92% | 14TCr | |
| -1.74% | +8.81% | -3.03% | -17.89% | 14TCr | |
| -1.70% | -4.00% | -59.19% | -18.65% | 6.57TCr | |
| -0.47% | -0.50% | -27.38% | -32.98% | 4.35TCr | |
| -2.34% | +4.54% | +11.46% | +14.14% | 3.84TCr | |
| -1.48% | +3.78% | +4.67% | +43.28% | 3.68TCr | |
| -1.08% | +5.62% | -12.54% | -15.73% | 2.99TCr | |
| -0.93% | +5.20% | -22.23% | -7.57% | 2.89TCr | |
| Average | -0.76% | +4.75% | -9.15% | -1.34% | 7.68TCr | |
| Weighted average by Cap. | -0.77% | +5.60% | -5.06% | -0.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 674.8Cr 590.68Cr 544.91Cr 508.92Cr 958.62Cr 64TCr 979.56Cr 6.55TCr 2.53TCr 31TCr 2.53TCr 2.48TCr 1,09300Cr | 741.05Cr 648.67Cr 598.41Cr 558.88Cr 1.05TCr 70TCr 1.08TCr 7.2TCr 2.78TCr 35TCr 2.78TCr 2.72TCr 1,20000Cr |
| Net income | 162.43Cr 142.18Cr 131.16Cr 122.5Cr 230.75Cr 15TCr 235.79Cr 1.58TCr 609.01Cr 7.57TCr 609.94Cr 596.59Cr 26TCr | 189.11Cr 165.54Cr 152.71Cr 142.62Cr 268.65Cr 18TCr 274.52Cr 1.84TCr 709.06Cr 8.82TCr 710.14Cr 694.59Cr 31TCr |
| Net Debt | -348.23Cr -304.82Cr -281.2Cr -262.63Cr -494.7Cr -33TCr -505.5Cr -3.38TCr -1.31TCr -16TCr -1.31TCr -1.28TCr -56TCr | -507.26Cr -444.03Cr -409.62Cr -382.56Cr -720.61Cr -48TCr -736.36Cr -4.93TCr -1.9TCr -24TCr -1.9TCr -1.86TCr -82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $91.18 | +0.44% | 34,98,190 |
| 26/26/26 | $90.78 | +1.18% | 1,44,20,825 |
| 25/26/25 | $89.72 | +0.07% | 43,18,766 |
| 24/26/24 | $89.66 | +3.12% | 45,11,691 |
| 23/26/23 | $86.95 | +1.25% | 42,28,237 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
